Therapeutic antibodies in ophthalmology: old is new again.

Therapeutic antibodies in ophthalmology: old is new again.

Item
http://www.wikidata.org/entity/Q37848065
Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.Lasting controversy on ranibizumab and bevacizumab.Current Perspectives on the Use of Anti-VEGF Drugs as Adjuvant Therapy in Glaucoma.Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders.Current and investigational pharmacotherapeutic approaches for modulating retinal angiogenesis.Sudden visual loss in the untreated eye of a patient with neovascular glaucoma following an intravitreal bevacizumab injection: A case report.Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.Randomized, controlled trial of conjunctival autografting combined with subconjunctival bevacizumab for primary pterygium treatment: 1-year follow-up.
P2860

Therapeutic antibodies in ophthalmology: old is new again.

Item
http://www.wikidata.org/entity/Q37848065
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic antibodies in ophthalmology: old is new again.
@en
Therapeutic antibodies in ophthalmology: old is new again.
@nl
type
label
Therapeutic antibodies in ophthalmology: old is new again.
@en
Therapeutic antibodies in ophthalmology: old is new again.
@nl
prefLabel
Therapeutic antibodies in ophthalmology: old is new again.
@en
Therapeutic antibodies in ophthalmology: old is new again.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Therapeutic antibodies in ophthalmology: old is new again.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932